Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
Jack A. Roth, E. Neely Atkinson, Frank V. Fossella et al. · Lung Cancer · 1998
Cited by 447 works. doi:10.1016/s0169-5002(98)00046-4
Authors
- Jack A. Roth
- E. Neely Atkinson
- Frank V. Fossella
- Ritsuko K. Komaki
- Michael Ryan
- Joe Bill Putnam
- Jin Soo Lee
- Hari M. Dhingra
- Louis De Caro
- Marvin H. Chasen
- Waun Ki Hong
References
- Analysis of Survival Data
- Theoretical Statistics
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
- Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients
- The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.
- Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
- Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer
- Preoperative Chemotherapy (Cisplatin and Fluorouracil) and Radiation Therapy in Stage III Non-Small-Cell Lung Cancer: A Phase II Study of the Lung Cancer Study Group